Dietary Nrf2 activators inhibit atherogenic processes

Atherosclerosis

Volumn 225, Issue 1, 2012, Pages 29-33

  Juurlink, Bernhard H J ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b ALFAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Anti oxidant mechanisms; Anti oxidant response element; Atherosclerosis; Diet; Phase 2 protein inducers; Sulforaphane

Indexed keywords

AURANTIIN; CURCUMIN; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; SULFORAPHANE; TRANSCRIPTION FACTOR NRF2; ISOTHIOCYANIC ACID DERIVATIVE; SULFORAFAN; THIOCYANIC ACID DERIVATIVE;

ATHEROGENESIS; CELL DAMAGE; CELL METABOLISM; DIETARY INTAKE; ENZYME ACTIVATION; GENE EXPRESSION; GRAPEFRUIT JUICE; INFLAMMATION; NONHUMAN; NOTE; NUCLEAR LOCALIZATION SIGNAL; OXIDATIVE STRESS; PREMENOPAUSE; PRIORITY JOURNAL; ANIMAL;

ANIMALS; ISOTHIOCYANATES; THIOCYANATES;

EID: 84867856142     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.08.032     Document Type: Note

References (85)

1. Moore M.C., Guzman M.A., Schilling P.E., Strong J.P. Dietary-atherosclerosis study on deceased persons. J Am Diet Assoc 1981, 79:668-672.
2. Zhang X., Shu X.O., Xiang Y.B., et al. Cruciferous vegetable consumption is associated with a reduced risk of total and cardiovascular disease mortality. Am J Clin Nutr 2011, 94:240-246.
3. Keum Y.S. Regulation of the Keap1/Nrf2 system by chemopreventive sulforaphane: implications of posttranslational modifications. Ann N Y Acad Sci 2011, 1229:184-189.
4. Alexander R.W. Atherosclerosis as disease of redox-sensitive genes. Trans Am Clin Climatol Assoc 1998, 109:129-145.
5. Hulsmans M., Holvoet P. The vicious circle between oxidative stress and inflammation in atherosclerosis. J Cell Mol Med 2010, 14:70-78.
6. Junqueira V.B., Barros S.B., Chan S.S., et al. Aging and oxidative stress. Mol Aspects Med 2004, 25:5-16.
7. Cho C.G., Kim H.J., Chung S.W., et al. Modulation of glutathione and thioredoxin systems by calorie restriction during the aging process. Exp Gerontol 2003, 38:539-548.
8. Liu R., Choi J. Age-associated decline in gamma-glutamylcysteine synthetase gene expression in rats. Free Radic Biol Med 2000, 28:566-574.
9. Liu R.M. Down-regulation of gamma-glutamylcysteine synthetase regulatory subunit gene expression in rat brain tissue during aging. J Neurosci Res 2002, 68:344-351.
10. Sekhar R.V., Patel S.G., Guthikonda A.P., et al. Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. Am J Clin Nutr 2011, 94:847-853.
11. Suh J.H., Shenvi S.V., Dixon B.M., et al. Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci U S A 2004, 101:3381-3386.
12. Ungvari Z., Bailey-Downs L., Gautam T., et al. Age-associated vascular oxidative stress, Nrf2 dysfunction, and NF-{kappa}B activation in the nonhuman primate Macaca mulatta. J Gerontol A Biol Sci Med Sci 2011, 66:866-875.
13. Kensler T.W., Egner P.A., Agyeman A.S., et al. Keap1-Nrf2 signaling: a target for cancer prevention by sulforaphane. Top Curr Chem 2012.
14. Li W., Yu S.W., Kong A.N. Nrf2 possesses a redox-sensitive nuclear exporting signal in the Neh5 transactivation domain. J Biol Chem 2006, 281:27251-27263.
15. Glutathione Meister A. Ann Rev Biochem 1983, 79:711-760.
16. Wild A.C., Mulcahy R.T. Regulation of gamma-glutamylcysteine synthetase subunit gene expression: insights into transcriptional control of antioxidant defenses. Free Radic Res 2000, 32:281-301.
17. Ishii T., Itoh K., Takahashi S., et al. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 2000, 275:16023-16029.
18. Thimmulappa R.K., Mai K.H., Srisuma S., Kensler T.W., Yamamoto M., Biswal S. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res 2002, 62:5196-5203.
19. Hayes J.D., Pulford D.J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995, 30:445-600.
20. Miyamoto N., Izumi H., Miyamoto R., et al. Quercetin induces the expression of peroxiredoxins 3 and 5 via the Nrf2/NRF1 transcription pathway. Invest Ophthalmol Vis Sci 2011, 52:1055-1063.
21. Primiano T., Gastel J.A., Kensler T.W., Sutter T.R. Isolation of cDNAs representing dithiolethione-responsive genes. Carcinogenesis 1996, 17:2297-2303.
22. Campagne M.V., Thibodeaux H., van Bruggen N., Cairns B., Lowe D.G. Increased binding activity at an antioxidant-responsive element in the metallothionein-1 promoter and rapid induction of metallothionein-1 and -2 in response to cerebral ischemia and reperfusion. J Neurosci 2000, 20:5200-5207.
23. Schrader C., Graeser A.C., Huebbe P., Wagner A.E., Rimbach G. Allyl isothiocyanate as a potential inducer of paraoxonase-1-studies in cultured hepatocytes and in mice. IUBMB Life 2012, 64:162-168.
24. Goyal T., Mitra S., Khaidakov M., et al. Current concepts of the role of oxidized LDL receptors in atherosclerosis. Curr Atheroscler Rep 2012.
25. Zhang Y., Talalay P., Cho C.G., Posner G.H. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci U S A 1992, 89:2399-2403.
26. Fahey J.W., Zhang Y., Talalay P. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci U S A 1997, 94:10367-10372.
27. Talalay P., Fahey J.W., Holtzclaw W.D., Prestera T., Zhang Y. Chemoprotection against cancer by phase 2 enzyme induction. Toxicol Lett 1995, 82-83:173-179.
28. Husain J., Juurlink B.H. Oligodendroglial precursor cell susceptibility to hypoxia is related to poor ability to cope with reactive oxygen species. Brain Res 1995, 698:86-94.
29. Juurlink B.H., Sweeney M.I. Mechanisms that result in damage during and following cerebral ischemia. Neurosci Biobehav Rev 1997, 21:121-128.
30. Juurlink B.H. Therapeutic potential of dietary phase 2 enzyme inducers in ameliorating diseases that have an underlying inflammatory component. Can J Physiol Pharmacol 2001, 79:266-282.
31. Juurlink B.H.J. Dietary phase 2 protein inducers and atherosclerosis 2004, International Atherosclerosis Society Commentaries. http://www.athero.org/comm-index1.asp.
32. Noyan-Ashraf M.H., Sadeghinejad Z., Juurlink B.H. Dietary approach to decrease aging-related CNS inflammation. Nutr Neurosci 2005, 8:101-110.
33. Wu L., Noyan Ashraf M.H., Facci M., et al. Dietary approach to attenuate oxidative stress, hypertension, and inflammation in the cardiovascular system. Proc Natl Acad Sci U S A 2004, 101:7094-7099.
34. Noyan-Ashraf M.H., Wu L., Wang R., Juurlink B.H. Dietary approaches to positively influence fetal determinants of adult health. FASEB J 2006, 20:371-373.
35. Noyan-Ashraf M.H., Sadeghinejad Z., Davies G.F., et al. Phase 2 protein inducers in the diet promote healthier aging. J Gerontol A Biol Sci Med Sci 2008, 63:1168-1176.
36. Collins T., Read M.A., Neish A.S., Whitley M.Z., Thanos D., Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J 1995, 9:899-909.
37. McFarlane S.M., Pashmi G., Connell M.C., et al. Differential activation of nuclear factor-kappaB by tumour necrosis factor receptor subtypes. TNFR1 predominates whereas TNFR2 activates transcription poorly. FEBS Lett 2002, 515:119-126.
38. Moe K.T., Aulia S., Jiang F., et al. Differential upregulation of Nox homologues of NADPH oxidase by tumor necrosis factor-alpha in human aortic smooth muscle and embryonic kidney cells. J Cell Mol Med 2006, 10:231-239.
39. Wu C., Ghosh S. Differential phosphorylation of the signal-responsive domain of I kappa B alpha and I kappa B beta by I kappa B kinases. J Biol Chem 2003, 278:31980-31987.
40. Flohé L., Brigelius-Flohe R., Saliou C., Traber M.G., Packer L. Redox regulation of NF-kappa B activation. Free Radic Biol Med 1997, 22:1115-1126.
41. Loukili N., Rosenblatt-Velin N., Rolli J., et al. Oxidants positively or negatively regulate nuclear factor kappaB in a context-dependent manner. J Biol Chem 2010, 285:15746-15752.
42. Salmeen A., Barford D. Functions and mechanisms of redox regulation of cysteine-based phosphatases. Antioxid Redox Signal 2005, 7:560-577.
43. McCubrey J.A., Lahair M.M., Franklin R.A. Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid Redox Signal 2006, 8:1775-1789.
44. Wang J., An F.S., Zhang W., et al. Inhibition of c-Jun N-terminal kinase attenuates low shear stress-induced atherogenesis in apolipoprotein E-deficient mice. Mol Med 2011, 17:990-999.
45. Zakkar M., Chaudhury H., Sandvik G., et al. Increased endothelial mitogen-activated protein kinase phosphatase-1 expression suppresses proinflammatory activation at sites that are resistant to atherosclerosis. Circ Res 2008, 103:726-732.
46. Wu L., Juurlink B.H. The impaired glutathione system and its up-regulation by sulforaphane in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens 2001, 19:1819-1825.
47. Umetani M., Mataki C., Minegishi N., Yamamoto M., Hamakubo T., Kodama T. Function of GATA transcription factors in induction of endothelial vascular cell adhesion molecule-1 by tumor necrosis factor-alpha. Arterioscler Thromb Vasc Biol 2001, 21:917-922.
48. Burch J.B. Regulation of GATA gene expression during vertebrate development. Semin Cell Dev Biol 2005, 16:71-81.
49. Buggisch M., Ateghang B., Ruhe C., et al. Stimulation of ES-cell-derived cardiomyogenesis and neonatal cardiac cell proliferation by reactive oxygen species and NADPH oxidase. J Cell Sci 2007, 120:885-894.
50. Ishida A., Iijima R., Kobayashi A., Maeda M. Characterization of cAMP-dependent proteolysis of GATA-6. Biochem Biophys Res Commun 2005, 332:976-981.
51. Brown D.M., Hutchison L., Donaldson K., MacKenzie S.J., Dick C.A., Stone V. The effect of oxidative stress on macrophages and lung epithelial cells: the role of phosphodiesterases 1 and 4. Toxicol Lett 2007, 168:1-6.
52. Meng T.C., Fukada T., Tonks N.K. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 2002, 9:387-399.
53. Kreuzer J., Viedt C., Brandes R.P., et al. Platelet-derived growth factor activates production of reactive oxygen species by NAD(P)H oxidase in smooth muscle cells through Gi1,2. FASEB J 2003, 17:38-40.
54. Hirschberg K., Radovits T., Korkmaz S., et al. Combined superoxide dismutase mimetic and peroxynitrite scavenger protects against neointima formation after endarterectomy in association with decreased proliferation and nitro-oxidative stress. Eur J Vasc Endovasc Surg 2010, 40:168-175.
55. Shishido T., Nozaki N., Takahashi H., et al. Central role of endogenous Toll-like receptor-2 activation in regulating inflammation, reactive oxygen species production, and subsequent neointimal formation after vascular injury. Biochem Biophys Res Commun 2006, 345:1446-1453.
56. Szocs K., Lassegue B., Sorescu D., et al. Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler Thromb Vasc Biol 2002, 22:21-27.
57. Zakkar M., Van der Heiden K., Luong le A., et al. Activation of Nrf2 in endothelial cells protects arteries from exhibiting a proinflammatory state. Arterioscler Thromb Vasc Biol 2009, 29:1851-1857.
58. Huang W.C., Chen J.J., Inoue H., Chen C.C. Tyrosine phosphorylation of I-kappa B kinase alpha/beta by protein kinase C-dependent c-Src activation is involved in TNF-alpha-induced cyclooxygenase-2 expression. J Immunol 2003, 170:4767-4775.
59. Myzak M.C., Hardin K., Wang R., Dashwood R.H., Ho E. Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells. Carcinogenesis 2006, 27:811-819.
60. Facci MR. The effect of a dietary phase 2 protein inducer on inflammatory parameters in blood and liver of spontaneously hypertensive stroke prone rats. MSc disertation, Anatomy & Cell Biology, Saskatoon, SK, Canada: University of Saskatchewan; 2004: 97. http://sundog.usask.ca/search~S8?/afacci/afacci/1%252C14%252C17%252CB/frameset&FF=afacci%2Bmarina%2Brita&1%252C1%252C.
61. Vatsala T.M., Singh M., Murugesan R.G. Effects of onion in induced atherosclerosis in rabbits: I. Reduction of arterial lesions and lipid levels. Artery 1980, 7:519-530.
62. Efendy J.L., Simmons D.L., Campbell G.R., Campbell J.H. The effect of the aged garlic extract, 'Kyolic', on the development of experimental atherosclerosis. Atherosclerosis 1997, 132:37-42.
63. Li X.H., Li C.Y., Lu J.M., Tian R.B., Wei J. Allicin ameliorates cognitive deficits ageing-induced learning and memory deficits through enhancing of Nrf2 antioxidant signaling pathways. Neurosci Lett 2012, 514:46-50.
64. Chen C., Pung D., Leong V., et al. Induction of detoxifying enzymes by garlic organosulfur compounds through transcription factor Nrf2: effect of chemical structure and stress signals. Free Radic Biol Med 2004, 37:1578-1590.
65. Myhrstad M.C., Carlsen H., Nordstrom O., Blomhoff R., Moskaug J.J. Flavonoids increase the intracellular glutathione level by transactivation of the gamma-glutamylcysteine synthetase catalytical subunit promoter. Free Radic Biol Med 2002, 32:386-393.
66. Abramovitz D., Gavri S., Harats D., et al. Allicin-induced decrease in formation of fatty streaks (atherosclerosis) in mice fed a cholesterol-rich diet. Coron Artery Dis 1999, 10:515-519.
67. Lei Y.P., Chen H.W., Sheen L.Y., Lii C.K. Diallyl disulfide and diallyl trisulfide suppress oxidized LDL-induced vascular cell adhesion molecule and E-selectin expression through protein kinase A- and B-dependent signaling pathways. J Nutr 2008, 138:996-1003.
68. Lei Y.P., Liu C.T., Sheen L.Y., Chen H.W., Lii C.K. Diallyl disulfide and diallyl trisulfide protect endothelial nitric oxide synthase against damage by oxidized low-density lipoprotein. Mol Nutr Food Res 2010, 54(Suppl. 1):S42-S52.
69. Kleemann R., Verschuren L., Morrison M., et al. Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models. Atherosclerosis 2011, 218:44-52.
70. Bhaskar S., Kumar K.S., Krishnan K., Antony H. Quercetin alleviates hypercholesterolemic diet induced inflammation during progression and regression of atherosclerosis in rabbits. Nutrition 2012.
71. Wang W., Liu L.Q., Higuchi C.M., Chen H. Induction of NADPH:quinone reductase by dietary phytoestrogens in colonic Colo205 cells. Biochem Pharmacol 1998, 56:189-195.
72. Prasad K. Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation 1999, 99:1355-1362.
73. Prasad K. Regression of hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Atherosclerosis 2008, 197:34-42.
74. Balogun E., Hoque M., Gong P., et al. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J 2003, 371:887-895.
75. Quiles J.L., Mesa M.D., Ramirez-Tortosa C.L., et al. Curcuma longa extract supplementation reduces oxidative stress and attenuates aortic fatty streak development in rabbits. Arterioscler Thromb Vasc Biol 2002, 22:1225-1231.
76. Coban D., Milenkovic D., Chanet A., et al. Dietary curcumin inhibits atherosclerosis by affecting the expression of genes involved in leukocyte adhesion and transendothelial migration. Mol Nutr Food Res 2012.
77. Gopinath K., Sudhandiran G. Naringin modulates oxidative stress and inflammation in 3-nitropropionic acid-induced neurodegeneration through the activation of Nrf2 signalling pathway. Neuroscience 2012.
78. Chanet A., Milenkovic D., Deval C., et al. Naringin, the major grapefruit flavonoid, specifically affects atherosclerosis development in diet-induced hypercholesterolemia in mice. J Nutr Biochem 2012, 23:469-477.
79. Kiechl S., Willeit J. The natural course of atherosclerosis. Part I: incidence and progression. Arterioscler Thromb Vasc Biol 1999, 19:1484-1490.
80. Lee J.M., Anderson P.C., Padgitt J.K., Hanson J.M., Waters C.M., Johnson J.A. Nrf2, not the estrogen receptor, mediates catechol estrogen-induced activation of the antioxidant responsive element. Biochim Biophys Acta 2003, 1629:92-101.
81. Sumi D., Numasawa Y., Endo A., Iwamoto N., Kumagai Y. Catechol estrogens mediated activation of Nrf2 through covalent modification of its quinone metabolite to Keap1. J Toxicol Sci 2009, 34:627-635.
82. Katsiki N., Manes C. Is there a role for supplemented antioxidants in the prevention of atherosclerosis?. Clin Nutr 2009, 28:3-9.
83. Lonn M.E., Dennis J.M., Stocker R. Actions of " antioxidants" in the protection against atherosclerosis. Free Radic Biol Med 2012, 53:863-884.
84. Ornish D., Scherwitz L.W., Billings J.H., et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA 1998, 280:2001-2007.
85. Dod H.S., Bhardwaj R., Sajja V., et al. Effect of intensive lifestyle changes on endothelial function and on inflammatory markers of atherosclerosis. Am J Cardiol 2010, 105:362-367.